​Standard 13cm length and 23cm Long model for access beyond the right subclavian-SVC junction

​Extruded score line peel-away sheath for clean, even peel

​Longer, smoother sheath tip to dilator transition for ease during sheath insertion

​Lubricated hemostatic valve with low insertion and withdrawal forces yields greater control during lead manipulation, reducing risk of blood loss and air embolism

​Convenient sideport for infusion and contrast injection

​Wide range of French sizes

​French size printed on handle and indicated by color-coded introducer cap

​Elastomer snap-locking dilator connector with French size embossed on handle

​Ergonomic, easy-splitting break-away hub

In 1994, Pressure Products revolutionized vascular access with the introduction of the SafeSheath® hemostatic-valved, peel-away introducer system, providing problem-free vascular access during device lead placement for more than 18 years.

Now, SafeSheath II advances the original design, continuing to revolutionize venous access by setting new standards for performance and features while facilitating better outcomes.

SafeSheath II Introduced into the subclavian vein in the standard manner, the hemostatic valve of the SafeSheath II seals the device during lead introduction and positioning.

The easy splitting, ergonomically-shaped break-away hub greatly simplifies sheath removal after lead or catheter placement. Extruded score line construction ensures a clean, even peel every time. A new elastomer snap-locking dilator connector assures a firm attachment to the sheath.

The three-way stopcock side port  provides a convenient means of aspirating and flushing the introducer, as well as for contrast and fluid administration.

Finally, the advanced design of the lubricated hemostatic valve enables low insertion and withdrawal forces, delivering greater control during lead manipulation.

SafeSheath II Long  The 23cm Long provides access beyond the right subclavian-SVC junction, from both the left cephalic and subclavian veins. The extra length helps when upgrading existing systems by the addition of new leads and for atypical venous access sites—axillary or femoral. It also acts as a ‘supporting’ platform for the introduction of defibrillator leads.